Persistence of chlamydia pneumoniae in human atherosclerotic plaques material - Evidence and consequences;Persistenz von chlamydia pneumoniae in humanem arteriosklerotischen plaquematerial - Evidenzen und konsequenzen

Herz

Volumn 23, Issue 3, 1998, Pages 178-184

  Maass, Matthias ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Arteriosclerosis; Chlamydia pneumoniae; Coronary heart disease

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; PATHOGENESIS;

EID: 0031981610     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044603     Document Type: Article

References (41)

1. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection. Proc Natl Acad Sci USA 1993;90:3998-4002.
2. Blasi F, Denti F, Erba M, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996;34:2766-9.
3. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-8.
4. Dalhoff K, Maass M. Chlamydia pneumoniae pneumonia in hospitalized patients: Clinical characteristics and diagnostic value of PCR detection in BAL. Chest 1996;110:351-6.
5. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
6. Fong IW, Chiu B, Viira E, et al. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997;35:48-52.
7. Godzik KL, O'Brien ER, Wang SK, et al. In vitro suceptibility of human vascular cells to infection with Chlamydia pneumoniae. J Clin Microbiol 1995;33:2411-4.
8. Grayston JT, Kuo CC, Campbell LA, et al. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur Heart J 1993;14:Suppl K:66-71.
9. Grayston JT, Kuo CC, Coulson AS, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-400.
10. Grayston JT, Kuo CC, Wang SP, et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-8.
11. Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
12. Gurfinkel E, Bozovich G, Daroca A, et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997;350:404-7.
13. Holtman H, Shemer-Avni Y, Wessel K, et al. Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor alpha is accompanied by increased prostaglandin production. Infect Immun 1990;58:3168-72.
14. Jackson LA, Campbell LA, Kuo CC, et al. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997;176:292-5.
15. Kawakami M, Pekala PH, Lance MD, et al. Lipoprotein lipase suppression in T3T L1 cells by an induced mediator from exudate cells. Proc Natl Acad Sci USA 1983;79:912-6.
16. Kuo CC, Campbell LA, Cappuccio AL, et al. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg 1997;26:29-31.
17. Kuo CC, Gown AM, Benditt EP, et al. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscl Thromb 1993;13:1501-4.
18. Kuo CC, Grayston JT, Campbell LA, et al. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995;92:6911-4.
19. Kuo CC, Jackson LA, Campbell LA, et al. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-61.
20. Kuo CC, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
21. Laitinen K, Laurila A, Pyhala L, et al. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 1998;65:4832-5.
22. Laurila A, Bloigu A, Nayha S, et al. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscl Thromb 1997;17:2910-3.
23. Maass M, Bartels C, Engel PM, et al. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardioll 1998;31:827-32.
24. Maass M, Bartels C, Krüger S, et al. Endovascular presence of Chlamydia pneumoniae is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis (in press).
25. Maass M, Engel, PM, Bartels C, et al. Chlamydia pneumoniae nutzt Makrophagen als Vektoren für den Zugang zum Gefäßsystem. 49. Kongreß der Deutschen Gesellschaft fũr Hygiene und Mikrobiologie, Jena. 5. - 9. 10. 1997.
26. Maass M, Gieffers J. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol Infect Dis 1996;6:65-70.
27. Maass M, Gieffers J. Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile. J Infect 1997;35:171-6.
28. Maass M, Harig U. Evaluation of culture conditions used for isolation of Chlamydia pneumoniae. Am J Clin Pathol 1995;103:141-8.
29. Maass M, Krause E, Engel PM, et al. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology 1997;48:699-706.
30. Moazed TC, Kuo CC, Grayston JT, et al. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997;175:883-90.
31. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-61.
32. Ong G, Thomas BJ, Mansfield AO, et al. Detection and wide-spread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996;49:102-6.
33. Ramirez JA. Chlamydia pneumoniae/Atherosclerosis Study Group: Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary arteriosclerosis. Ann Intern Med 1996;125:979 -82.
34. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995;57:791-804.
35. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
36. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart study. Ann Intern Med 1992;116:273-8.
37. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992;82:158-61.
38. Suzuki H, Kurihara Y, Takeya M, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997;386:292-6.
39. Thorn DH, Grayston JT, Siscovick DS, et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
40. Ward ME. The immunobiology and immunopathology of chlamydial infections. APMIS 1995;103:769-96.
41. Weiss SM, Roblin PM, Gaydos CA, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996;173:957-62.